Medication info

Univis Tablet

Prescription medicationApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›Strength being verifiedTripotassium Bismuth Dicitrate›Strength being verifiedSucralfate Hydrate›Strength being verified
Manufacturer / importer
Korea Union Pharmaceutical Co., Ltd.
Appearance
White, round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201902470 · Approved 2019.04.22

This product's status changed to Approval withdrawn on 2023.04.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as gastric ulcers and gastritis) and prevention of Mendelson's syndrome
Who uses it
Adults
Adult dosage
○ Adults Usually, irrespective of meals, administer 2 tablets orally twice a day, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice a day or 4 tablets once a day at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice a day, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent the development of gastric or duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. These conditions usually heal within 4 weeks, or within 8 weeks in the case of conditions caused by nonsteroidal anti-inflammatory drugs; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once a day at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 2 tablets twice a day or 4 tablets once a day at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times a day. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times a day, and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice a day. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Korea Union Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as gastric ulcers and gastritis) and prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs
View approved original text

This medication is used to treat gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease, and is also effective for conditions caused by excessive gastric acid secretion, such as Zollinger-Ellison syndrome. Additionally, it helps prevent Mendelson's syndrome during preoperative anesthesia and postoperative ulcers, and is used for the treatment of ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). This drug is widely utilized for the treatment and prevention of various gastric-related diseases.

Dosage and Administration

Adult dosage

○ Adults Usually, irrespective of meals, administer 2 tablets orally twice a day, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice a day or 4 tablets once a day at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice a day, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent the development of gastric or duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. These conditions usually heal within 4 weeks, or within 8 weeks in the case of conditions caused by nonsteroidal anti-inflammatory drugs; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once a day at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 2 tablets twice a day or 4 tablets once a day at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times a day. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times a day, and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice a day. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Precautions

This drug should not be used in patients undergoing hemodialysis or those allergic to its components. It should also be avoided in cases of rare conditions like acute porphyria or renal impairment. Patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, and premature or newborn infants are also advised against using this medication. Patients on a potassium-restricted diet should be cautious. It should be used with caution in patients with impaired liver function, those with a history of drug allergies, the elderly, and patients with previous kidney issues. Periodic checks on gastrointestinal status are particularly necessary for those taking non-steroidal anti-inflammatory drugs. This drug can mask symptoms of gastric cancer, so patients with gastric ulcers or those over middle age who recently developed indigestion symptoms should be evaluated for malignancy before use. Patients with gastric ulcers infected with Helicobacter pylori should receive eradication therapy as well. Severe patients, patients with hypophosphatemia, and those with dysphagia should also be monitored closely while using this drug. Serious allergic reactions such as anaphylactic shock may occur rarely, so if any unusual symptoms occur, administration should be stopped immediately, and healthcare personnel should be informed. Symptoms of hypersensitivity such as skin rash, urticaria, bronchospasm, and hypotension may also occur, so caution is advised. Decreased blood cell counts, abnormal liver function, arrhythmias, gastrointestinal symptoms, and neurological issues have been reported, so if any unusual symptoms occur, consultation is advised. If there is no treatment effect without long-term use, it is recommended to change to another medication, and regular blood tests and liver and kidney function tests are necessary. The elderly, patients with chronic lung disease, diabetes, and those with weakened immune systems may have an increased risk of pneumonia, so caution is warranted. If dizziness or drowsiness occurs, it is advised to avoid driving or operating dangerous machinery. When taking other medications, there may be drug interactions, so it is important to discuss with a doctor or pharmacist, especially when taking certain antibiotics, heart medications, or anticonvulsants, and spacing doses apart may be necessary. It is safest for pregnant or nursing women not to use this drug. The safety and efficacy of this medication have not been sufficiently established in children and its use is not recommended. In case of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and if needed, the drug can be removed via hemodialysis. This drug decreases gastric acid secretion, which may promote bacterial growth in the stomach, so regular check-ups, including eye examinations, are necessary with long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 58 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelodysplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusional state
  • convulsions
  • agitation
  • insomnia
  • headache
  • feeling of heaviness
  • illness perception
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • myoclonus
  • gynecomastia
  • hyperprolactinemia
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress, at a recommended temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its effectiveness and prevent deterioration.

Appearance and packaging

Appearance

White, round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.